STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS
The present disclosure relates to immunogenic compositions for inducing an immune response in a subject for the treatment and/or prevention of a Staphylococcus aureus infection. The immunogenic compositions disclosed herein comprise a S. aureus protein A (SpA) polypeptide and a S. aureus Leukocidin...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
06.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to immunogenic compositions for inducing an immune response in a subject for the treatment and/or prevention of a Staphylococcus aureus infection. The immunogenic compositions disclosed herein comprise a S. aureus protein A (SpA) polypeptide and a S. aureus Leukocidin A (LukA) and/or Leukocidin B (LukB) variant polypeptide. The present disclosure further relates to methods of generating an immune response against S. aureus in a subject that involve administering the disclosed immunogenic compositions.
La présente divulgation concerne des compositions immunogènes permettant d'induire une réponse immunitaire chez un sujet pour le traitement et/ou la prévention d'une infection à Staphylococcus aureus. Les compositions immunogènes de la divulgation comprennent un polypeptide de protéine A de S. aureus (SpA) et un polypeptide variant leucocidine A (LukA) et/ou leucocidine B (LukB) de S. aureus. La présente divulgation concerne en outre des méthodes de génération d'une réponse immunitaire contre S. aureus chez un sujet qui impliquent l'administration des compositions immunogènes divulguées. |
---|---|
Bibliography: | Application Number: CA20223215751 |